AAAAAA

   
Results: 1-17 |
Results: 17
Torsades de pointes caused by Mibefradil
Authors: Glaser, S Steinbach, M Opitz, C Wruck, U Kleber, FX
Citation: S. Glaser et al., Torsades de pointes caused by Mibefradil, EUR J HE FA, 3(5), 2001, pp. 627-630
Utility of the cardiological stress test
Authors: Kleber, FX
Citation: Fx. Kleber, Utility of the cardiological stress test, INTERNIST, 42(9), 2001, pp. 1233
Passive containment and reverse remodeling by a novel textile cardiac support device
Authors: Konertz, WF Shapland, JE Hotz, H Dushe, S Braun, JP Stantke, K Kleber, FX
Citation: Wf. Konertz et al., Passive containment and reverse remodeling by a novel textile cardiac support device, CIRCULATION, 104(12), 2001, pp. I270-I275
Impairment of ventilatory efficiency in heart failure - Response
Authors: Kleber, FX Vietzke, G Wernecke, KD Bauer, U Opitz, C Wensel, R Sperfeld, A Glaser, S
Citation: Fx. Kleber et al., Impairment of ventilatory efficiency in heart failure - Response, CIRCULATION, 103(18), 2001, pp. E97-E97
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure
Authors: Nieminen, MS Akkila, J Hasenfuss, G Kleber, FX Lehtonen, LA Mitrovic, V Nyquist, O Remme, WJ
Citation: Ms. Nieminen et al., Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure, J AM COL C, 36(6), 2000, pp. 1903-1912
Oxidative stress in the human heart is associated with changes in the antioxidative defense as shown after heart transplantation
Authors: Schimke, I Schikora, M Meyer, R Dubel, HP Modersohn, D Kleber, FX Baumann, G
Citation: I. Schimke et al., Oxidative stress in the human heart is associated with changes in the antioxidative defense as shown after heart transplantation, MOL C BIOCH, 204(1-2), 2000, pp. 89-96
Iloprost as inhalative or intravenous long-term treatment of patients withprimary pulmonary hypertension. Register of the Berlin Study Group for Pulmonary Hypertension
Authors: Ewert, R Opitz, C Wensel, R Winkler, J Hoffken, G Frank, W Berger, F Kleber, FX Hetzer, R
Citation: R. Ewert et al., Iloprost as inhalative or intravenous long-term treatment of patients withprimary pulmonary hypertension. Register of the Berlin Study Group for Pulmonary Hypertension, Z KARDIOL, 89(11), 2000, pp. 987-999
Relationship between impaired pulmonary diffusion and cardiopulmonary exercise capacity after heart transplantation
Authors: Ewert, R Wensel, R Bruch, L Mutze, S Bauer, U Plauth, M Kleber, FX
Citation: R. Ewert et al., Relationship between impaired pulmonary diffusion and cardiopulmonary exercise capacity after heart transplantation, CHEST, 117(4), 2000, pp. 968-975
Impairment of ventilatory efficiency in heart failure - Prognostic impact
Authors: Kleber, FX Vietzke, G Wernecke, KD Bauer, U Opitz, C Wensel, R Sperfeld, A Gliser, S
Citation: Fx. Kleber et al., Impairment of ventilatory efficiency in heart failure - Prognostic impact, CIRCULATION, 101(24), 2000, pp. 2803-2809
Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension
Authors: Wensel, R Opitz, CF Ewert, R Bruch, L Kleber, FX
Citation: R. Wensel et al., Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension, CIRCULATION, 101(20), 2000, pp. 2388-2392
Inhaled iloprost to treat severe pulmonary hypertension - An uncontrolled trial
Authors: Olschewski, H Ghofrani, HA Schmehl, T Winkler, J Wilkens, H Hoper, MM Behr, J Kleber, FX Seeger, W
Citation: H. Olschewski et al., Inhaled iloprost to treat severe pulmonary hypertension - An uncontrolled trial, ANN INT MED, 132(6), 2000, pp. 435
Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol
Authors: Hampton, JR Van Veldhuisen, DJ Cowley, AJ Kleber, FX Charlesworth, A
Citation: Jr. Hampton et al., Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol, EUR J HE FA, 1(1), 1999, pp. 89-93
Management of patients with acute myocardial infarction at five academic medical centers: Clinical characteristics, resource utilization, and outcome
Authors: Matsui, K Polanczyk, CA Gaspoz, JM Theres, H Kleber, FX Sobashima, A Okamatsu, S Viana, JM Ribeiro, JP Emonet, S Lee, TH
Citation: K. Matsui et al., Management of patients with acute myocardial infarction at five academic medical centers: Clinical characteristics, resource utilization, and outcome, J INVES MED, 47(3), 1999, pp. 134-140
Acetylcholine but not sodium nitroprusside exerts vasodilation in pulmonary hypertension secondary to chronic congestive heart failure
Authors: Wensel, R Opitz, CF Kleber, FX
Citation: R. Wensel et al., Acetylcholine but not sodium nitroprusside exerts vasodilation in pulmonary hypertension secondary to chronic congestive heart failure, J HEART LUN, 18(9), 1999, pp. 877-883
Pulmonary artery stenosis 5 years after single lung transplantation in primary pulmonary hypertension
Authors: Waurick, PE Kleber, FX Ewert, R Pfitzmann, R Bruch, L Hummel, M Hetzer, R
Citation: Pe. Waurick et al., Pulmonary artery stenosis 5 years after single lung transplantation in primary pulmonary hypertension, J HEART LUN, 18(12), 1999, pp. 1243-1245
Medical therapy of acute heart failure
Authors: Kleber, FX
Citation: Fx. Kleber, Medical therapy of acute heart failure, Z KARDIOL, 88(6), 1999, pp. 394
Cardio-pulmonary exercise testing as a screening method in mitochondrial disorders
Authors: Sperfeld, A Vietzke, G Kleber, FX Ludolph, AC
Citation: A. Sperfeld et al., Cardio-pulmonary exercise testing as a screening method in mitochondrial disorders, NERVENARZT, 70(2), 1999, pp. 155-161
Risultati: 1-17 |